 Staphylococcus aureus
"Staphylococcus aureus" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Potentially pathogenic bacteria found in nasal membranes, skin, hair follicles, and perineum of warm-blooded animals. They may cause a wide range of infections and intoxications.
| Descriptor ID |
D013211
|
| MeSH Number(s) |
B03.300.390.400.800.750.100 B03.353.500.750.750.100 B03.510.100.750.750.100 B03.510.400.790.750.100
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Staphylococcus aureus".
Below are MeSH descriptors whose meaning is more specific than "Staphylococcus aureus".
This graph shows the total number of publications written about "Staphylococcus aureus" by people in this website by year, and whether "Staphylococcus aureus" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 | | 1997 | 0 | 3 | 3 | | 1999 | 1 | 2 | 3 | | 2000 | 1 | 1 | 2 | | 2001 | 2 | 3 | 5 | | 2002 | 1 | 0 | 1 | | 2003 | 1 | 1 | 2 | | 2004 | 1 | 2 | 3 | | 2005 | 0 | 1 | 1 | | 2006 | 6 | 0 | 6 | | 2007 | 9 | 3 | 12 | | 2008 | 7 | 3 | 10 | | 2009 | 8 | 4 | 12 | | 2010 | 8 | 2 | 10 | | 2011 | 13 | 5 | 18 | | 2012 | 7 | 3 | 10 | | 2013 | 19 | 6 | 25 | | 2014 | 10 | 4 | 14 | | 2015 | 8 | 3 | 11 | | 2016 | 12 | 4 | 16 | | 2017 | 7 | 3 | 10 | | 2018 | 12 | 5 | 17 | | 2019 | 15 | 5 | 20 | | 2020 | 13 | 3 | 16 | | 2021 | 11 | 5 | 16 | | 2022 | 5 | 12 | 17 | | 2023 | 8 | 11 | 19 | | 2024 | 7 | 7 | 14 | | 2025 | 6 | 2 | 8 |
To return to the timeline, click here.
Below are the most recent publications written about "Staphylococcus aureus" by people in Profiles.
-
Ho EC, Butler M, Olson KE, Simmons D, Beveridge C, Miller K, Birkholz M, Jung SA, Dominguez SR. Validation of pleural fluid group A Streptococcus and Staphylococcus aureus PCR assays and their potential clinical impact in children with complicated pneumonia. J Microbiol Methods. 2025 Sep; 236:107192.
-
Teghanemt A, Schilcher K, Kavanaugh JS, Horswill AR, Nauseef WM. Mutation in Staphylococcus aureus that supports gain of function in susceptibility both to hypochlorous acid and to human neutrophils. J Leukoc Biol. 2025 Jul 09; 117(7).
-
Sul C, Lewis CV, Posey J, Jordan M, Colon Hidalgo D, Porfilio T, Elajaili H, McCormack G, Burciaga S, Delaney C, Nozik ES. Increased Circulating Extracellular Superoxide Dismutase Attenuates Platelet-Neutrophil Interactions. Am J Respir Cell Mol Biol. 2025 Jun; 72(6):653-662.
-
Cohen S, Horswill AR, Doran KS. Skin mycobiome: Fungi drive colonization resistance in an already hostile environment. Curr Biol. 2025 May 19; 35(10):R396-R398.
-
Craig A, Shihadeh KC, Knepper BC, Miller W, Young HL, Aragon D, Jenkins TC. Antibiotic adherence and treatment completion associated with partial oral therapy versus all intravenous therapy in patients with serious Staphylococcus aureus infections. BMC Infect Dis. 2025 May 17; 25(1):714.
-
Enroth TJ, Severn MM, Costa FG, Bovee AR, Wilkening RV, Nguyen DT, Langou?t-Astri? C, Horswill AR. Global changes in Staphylococcus aureus virulence and metabolism during colonization of healthy skin. Infect Immun. 2025 04 08; 93(4):e0002825.
-
Bhattacharya M, Scherr TD, Lister J, Kielian T, Horswill AR. Extracellular adherence proteins reduce matrix porosity and enhance Staphylococcus aureus biofilm survival during prosthetic joint infection. Infect Immun. 2025 Apr 08; 93(4):e0008625.
-
Mourad A, Nwafo N, Skalla L, Holland TL, Jenkins TC. Oral Versus Intravenous Antibiotic Therapy for Staphylococcus aureus Bacteremia or Endocarditis: A Systematic Review and Meta-Analysis of Randomized, Controlled Trials. Clin Infect Dis. 2025 02 05; 80(1):29-36.
-
Tamkin E, Lorenz BP, McCarty A, Fulte S, Eisenmesser E, Horswill AR, Clark SE. Airway Corynebacterium interfere with Streptococcus pneumoniae and Staphylococcus aureus infection and express secreted factors selectively targeting each pathogen. Infect Immun. 2025 02 18; 93(2):e0044524.
-
Kenney HM, Yoshida T, Berdyshev E, Calatroni A, Gill SR, Simpson EL, Lussier S, Boguniewicz M, Hata T, Chiesa Fuxench ZC, De Benedetto A, Ong PY, Ko J, Davidson W, David G, Schlievert PM, Leung DYM, Beck LA. CERS1 is a biomarker of Staphylococcus aureus abundance and atopic dermatitis severity. J Allergy Clin Immunol. 2025 Feb; 155(2):479-490.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|